EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Noriyuki Tabuchi
Hirokuni Arai
Hiroyuki Tanaka
Makoto Sunamori
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shimoyama, T.
Right arrow Articles by Sunamori, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shimoyama, T.
Right arrow Articles by Sunamori, M.
Related Collections
Right arrow Lung - transplantation
Right arrow Lung - basic science

Eur J Cardiothorac Surg 2005;28:581-587
© 2005 Elsevier Science NL


Original articles

Aprotinin attenuated ischemia–reperfusion injury in an isolated rat lung model after 18-hours preservation

Takehiko Shimoyama * , Noriyuki Tabuchi, Katsuo Kojima, Hideki Akamatsu, Hirokuni Arai, Hiroyuki Tanaka, Makoto Sunamori

Department of Cardio-thoracic Surgery, Graduate School of Medicine, Tokyo Medical and Dental University, Yushima 1-5-45, Bunkyo-ku, Tokyo 113-8519, Japan

Received 8 March 2005; received in revised form 27 May 2005; accepted 1 June 2005.

* Corresponding author. Tel.: +81 3 5803 5270; fax: +81 3 5803 0141. (Email: t-shim.tsrg{at}tmd.ac.jp).

Abstract

Objective: Ischemia–reperfusion injury is a major factor in the early phase of lung transplantation. We hypothesized that aprotinin, a nonspecific serine protease inhibitor, attenuates ischemia–reperfusion lung injury by inhibiting the inflammatory response and suppressing NADPH oxidase. Methods: We used an isolated rat lung model to test the above. A Control group was immediately perfused with fresh heparinized allogeneic blood after lung harvest without an ischemic period. Study lungs were flushed with low-potassium dextran (LPD) solution and stored for 18h at 4°C then divided into two groups: the LPD group was flushed with LPD solution only, and the LPD+A group was flushed with LPD solution +200KIU/ml aprotinin. Lungs in all three groups were then reperfused with fresh heparinized allogeneic blood for 120min at 37°C. Results: Throughout reperfusion, PO2 levels in the LPD+A group were similar to those in the Control group; although in the LPD group, PO2 levels were significantly lower (P<0.05). Tissue MDA levels were significantly higher in the LPD group than the Control and LPD+A groups (P<0.05). IL-8 levels were significantly higher in the LPD group than the Control group (P<0.05), while in the LPD+A group they were similar to those in the Control group. Histological evaluation showed interstitial edema accompanied by neutrophil extravasation in the LPD group, whereas this effect was modest in the LPD+A group. An additional study of ischemia–reperfusion in an alveolar macrophage culture showed that the activitvation of NADPH oxidase, and translocation of p47phox from the cytosol to the membrane were suppressed in aprotinin group. Conclusions: Aprotinin attenuates ischemia–reperfusion lung injury by inhibiting the early inflammatory response, neutrophil extravasation and the production of oxygen free radicals through inhibition of the activation of the NADPH oxidase. The inhibition of p47phox translocation in alveolar macrophage seemed involved in this mechanism of aprotinin.

Key Words: Aprotinin • Lung • Ischemia–reperfusion




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
I. Rubio-Gayosso, S. H. Platts, and B. R. Duling
Reactive oxygen species mediate modification of glycocalyx during ischemia-reperfusion injury
Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2247 - H2256.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
Y. A. B. Reyes, T. Shimoyama, H. Akamatsu, and M. Sunamori
MCI-186 (edaravone), a free radical scavenger, attenuates ischemia-reperfusion injury and activation of phospholipase A2 in an isolated rat lung model after 18 h of cold preservation
Eur. J. Cardiothorac. Surg., March 1, 2006; 29(3): 304 - 311.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2005 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.